Brooklyn ImmunoTherapeutics Inc (BTX)

[conix]

Brooklyn ImmumoTherapeutics hits new 52-week high; shares up 37%

Apr. 23, 2021

By: Jonathan M Block, SA News Editor

Shares of Brooklyn ImmunoTherapeutics (NYSEMKT:BTX) hit a new 52-week high this morning and are currently up 37%.

Shares are up nearly 97% in the last five days alone.

Earlier this month, the company acquired a license for a mRNA technology platform and brought in a new CEO.

The company's sole asset, IRX-2, is in phase 2b for squamous cell cancer of the head and neck and results are expected by the end of 1H 2021.